CTMX vs SWKS · rev $11.7M vs P/E 29, rev $4.09B
CytomX Therapeutics Inc (CTMX) versus Skyworks Solutions Inc (SWKS) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Skyworks Solutions Inc (SWKS) is a semiconductors company listed on NASDAQ.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported SWKS revenue for 2025-10-03 was $4.09B. Net income was $477.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
CTMX currently screens at market cap $653.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
Not investment advice. Open the CTMX and SWKS stock pages for the full models.
Not investment advice.